OOIR: Observatory of International Research

Papers

(The H4-Index of RSC Medicinal Chemistry is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di- N -oxide derivatives as potential antitubercular agents	125
Exploration of hydrazine-based small molecules as metal chelators for KDM4 inhibition	124
Integrating computational and experimental chemical biology revealed variable anticancer activities of phosphodiesterase isoenzyme 5 inhibitors (PDE5i) in lung cancer	116
Development of sulfonyl fluoride chemical probes to advance the discovery of cereblon modulators	107
N -Arylsulfonamide-based adenosine analogues to target RNA cap N 7-methyltransferase nsp14 of SARS-CoV-2	99
The effects of bioisostere substitution on the antimicrobial and physicochemical properties of supramolecular self-associating amphiphiles	97
Cytotoxicity of phosphoramidate, bis-amidate and cycloSal prodrug metabolites against tumour and normal cells	93
Integrated computational screen and validation of thalidomide-based PROTACs targeting SARS-CoV-2 main protease	80
Effect of mono-guanidine-like derivatives on platelet aggregation and tumour cell induced platelet aggregation	78
Inside front cover	77
Oxadiargyl analogs as potent inhibitors of Toxoplasma gondii protoporphyrinogen oxidase	74
Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery	73
Back cover	57
Back cover	51
Emerging opportunities in the rewiring of biology through proximity inducing small molecules	50
Triarylphosphonium-conjugated Sn( iv )-porphyrins for antimicrobial photodynamic therapy: impact of substituents on lipophilicity, aggregation, and p	47
Biocompatible glycolipid derived from bhilawanol as an antibiofilm agent and a promising platform for drug delivery	47
Emerging cellular uptake mechanisms of bRo5 PROTACs	41
Design, synthesis and structure–activity relationship analysis of dibenzodiazepinone derivatives against Osimertinib resistant NSCLC	41
Research progress of anticancer drugs targeting CDK12	40
Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies	40
New azole derivatives linked to indole/indoline moieties combined with FLC against drug-resistant Candida albicans	40
Exploring the potential of tamoxifen-based copper( ii ) dichloride in breast cancer therapy	39
Synthesis and biological evaluation of novel D-ring fused steroidal N (2)-substituted-1,2,3-triazoles	38
Design, synthesis, in vitro and in silico evaluation of indole-based tetrazole derivatives as putative ant	37

Unusual Ni⋯Ni interaction in Ni( ii ) complexes as potential inhibitors for the development of new anti-SARS-CoV-2 Omicron drugs	36
Thiazole orange-carboplatin triplex-forming oligonucleotide (TFO) combination probes enhance targeted DNA crosslinking	35
Targeting DNA-PK: medicinal chemistry insights into small-molecule inhibitor discovery and optimisation	33
Designing halogen-free metal–phenolic imidazolium poly(ionic liquids) with multi-functional antibacterial, anti-inflammatory and cell proliferation properties for infected wounds	32
Beta-cyclodextrin formulation of a disulfide-bond disrupting agent for improved systemic exposure	32
4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infections	31
ATP-competitive inhibitors for cancer treatment – kinases and the world beyond	31